results: C. amycolatum was the predominant species (20%) followed by C. striatum (16%). Penicillin was least effective invitro followed by clindamycin and ciprofloxacin. Excellent activities were shown by vancomycin, linezolid and imipenem. Multidrug resistance was found in all the species.
conclusion: Non-diphtheritic corynebacteria are potential nosocomial pathogens among acute/chronic complicated skin and soft tissue infection. Vancomycin or linezolid can be used empirically to treat such infections until the invitro susceptibility results are available.
of deionized water and using a sterile applicator stick several well isolated and similar colonies were smeared onto the surface. Development of red color within 5 minutes is considered positive for Beta-lactamase production.
stAtIstIcAl AnAlysIs
Statistical analysis was done using Epi Info™ 7. Fig-4 ]. C. amycolatum was the predominant species (20%) followed by C. striatum (16%).
Overall antibiotic resistance pattern of the isolates showed high frequency of resistance to penicillin followed by clindamycin and ciprofloxacin. Excellent activities were shown by vancomycin, linezolid and imipenem [Table/ Fig-4 ]. Beta-lactamase production was detected in 40% of isolates.
dIscussIOn
Corynebacterium spp can cause both acute and chronic wound infection [4, 13] . When a non-diphtheritic corynebacteria is isolated from clinical specimen, detailed patient profile and repeat microbiological analysis should be done before reporting it as contaminant [2, 10] . Antimicrobial susceptibility patterns of corynebacteria are not predictable and hence detection of antimicrobial susceptibility may be necessary in order to obtain the best therapeutic results.
In the present study all the diphtheroids were isolated from inpatients. Twenty four percent of samples grew diphtheroids in pure growth and 76% of isolates were obtained along with other bacteria. E coli (24%) was the commonest bacteria associated with diphtheroids followed by Klebsiella spp (12%), Pseudomonas aeruginosa (12%), Staphylococcus aureus (12%), Moraxella spp (8%), Enterococcus spp (4%) and Group C Streptococcus spp (4%). Initially cases were treated according to the susceptibility pattern of associated bacteria considering diphtheroids as possible skin commensals. After complete course of antibiotics, wound did not showed any signs of healing and repeat culture obtained same diphtheroids. Customized therapeutic combinations were designed according to the sensitivity pattern of diphtheroids and associated microorganisms for each patient. Treatment with such regimen showed very good response. The isolation of Corynebacterium species from clinically apparent skin and soft tissue infection and healing of lesions after appropriate antibiotic therapy suggest the pathogenic role of these organisms in our patients.
Current CLSI guidelines recommend detection of MIC as standard method of determining antibiotic sensitivity. Though BSAC recommend MIC as the standard method, it also recommends use of disc diffusion testing for few antibiotics [12] . CLSI recommends detection of MIC using Mueller Hinton broth enriched with 5% lysed horse blood in microtiter plates as standard method [11] . Many laboratories fail to determine MIC because of its complex procedure and lack of technical expertise. Automated systems like Vitek 2/ Phonix/API can determine sensitivity of diphtheroids [14] . But very few laboratories have this facility.
In the present study vancomycin (100%) was the most active drug against diphtheroids invitro followed by linezolid (96%) and imipenem (92%). Penicillin (0%) was least active drug followed by clindamycin (28%) and ciprofloxacin (32%). Similar findings were made by Soriano et al., and Camello et al., [5, 15] . Though vancomycin is the most active drug, resistance to the drug has been reported in C. aquaticum and CDC group B1 [15] . An isolate of C. riegelii showed an MIC of 16 µg/ml against linezolid. Resistance break point to linezolid for diphtheroids is not defined and hence judicious use of this drug is essential in clinical practice. Imipenem resistance was noted in one isolate of CDC group G from a case of post slit skin graft wound infection and one isolate of C. urealyticum from diabetic ketoacidosis with carbuncle. Both the patients were previously treated with carbapenems for non-healing ulcers leading to selection of imipenem resistant corynebacteria. Multidrug resistance was found in all Corynebacterium spp. Nosocomial outbreak of clonal multidrug resistant Corynebacterium spp has been recently reported [16] . In this study, chronic non-healing ulcers, advanced age, diabetes, longer duration of hospital stay and prolonged antibiotic therapy were the risk factors for diphtheroids infection. Most of the cases were from male and female surgical wards (n=9), plastic surgery ward (n=6) gynecology post-operative ward (n=6), intensive care unit (ICU) (n=2) and medical wards (n=2). Higher occurrence of cases in particular wards and multi-drug resistance among the strains, suggest the probable nosocomial origin of these bacteria. Coyle et al., using plasmid profiling as an epidemiological tool showed diphtheroids spread in hospitals from person to person and airborne modes [2] . Environmental contamination of wards may be the common source for infection. Proper infection control and surveillance activities are needed to control such infections.
lImItAtIOn
Limitation of the present study was smaller sample size. Further study has to be done on isolates obtained from larger geographical area to know the exact prevalence of skin and soft tissue infections due to non-diphtheritic corynebacteria.
cOnclusIOn
We conclude that non-diphtheritic corynebacteria are potential nosocomial pathogens among acute/chronic complicated skin and soft tissue infection. Wound infection with such organism causes delayed healing, raised treatment costs, and resource demanding wound management practices. We recommend vancomycin or linezolid be used empirically to treat complicated skin and soft tissue infections with non-diphtheritic corynebacteria and the ultimate therapeutic regimen against these organisms should be chosen according to the invitro susceptibility results, the site of the infection and associated microorganisms. 
